A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis

Title
A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 218, Issue 6, Pages 624.e1-624.e9
Publisher
Elsevier BV
Online
2018-03-13
DOI
10.1016/j.ajog.2018.03.001

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation